No. 18 / 2025 Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to ...

OTR Therapeutics, a biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for unmet medical needs, and Zealand Pharma A/S (Nasdaq: ZEAL), a ...

Report indicates that Mark Zuckerberg has other plans: to pull an open source U-turn and make Meta’s best AI models ...

AI PCs powered by processors like the AMD Ryzen AI processors mark a major shift in how we use artificial intelligence at ...

The Dow Jones Industrial Average rose in mixed trade Wednesday afternoon, ahead of an expected cut in interest rates by the ...

Clerx Services Ltd (ECLERX.NS), a leading productized services company, today announced that it has been named a Major Contender in Everest Group's 2025 Intelligent Process Automation Platform (IPA) ...

KB5072033 addresses vulnerabilities across Windows systems and Office applications—including one actively exploited zero-day.

Discover how Microsoft guides secure AI integration with governance, skills, and culture to reduce risks and accelerate ...

Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods.

Providence Microsoft rethinking cancer care with GigaTIME AI model that maps immune-tumor interactions across 24 cancer types for better treatment.

Explore TCHP ETF for concentrated mega-cap tech exposure. Learn if its growth focus and premium valuation fit your investment ...

Skip Clark, whose son Zach has Down syndrome, speaks with “Enable: The Disability Podcast” about the pain of hearing the ...